Clinical trial

Management of Insomnia in Breast Cancer Patients

NCT01011218

Study summary

ClinicalTrials.gov

Management of Insomnia in Breast Cancer Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

BEHAVIORAL · Unmapped registry intervention BBT-I Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Control Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Armodafinil Normalized identity: armodafinil View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-01-01

PhasePHASE2

Conditions

Insomniaverified · MONDO: insomnia

Fatigueunresolved

Interventions

BBT-IBEHAVIORAL

ControlBEHAVIORAL

ArmodafinilDRUG · verified · RxNorm: armodafinil

Sponsors & collaborators

Stanford Universitylead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

StanfordCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01011218 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.